Science Explorer Back to mapMap
Discussion
Researcher · Phio Pharmaceuticals (United States) · United States

Brianna Rivest

Brianna Rivest publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as CAR-T cell therapy research, Protein Degradation and Inhibitors and RNA Interference and Gene Delivery.

OpenAlex
World rank
#5,362,341
of 7,710,434 ranked researchers
Rank in United States
#1,363,163
of 1,627,098
Works
18
Citations
14
Citations per work
0.8
h-index
3
i10-index 0Top 99% in Molecular Biology
Brianna Rivest

What does Brianna Rivest research?

Brianna Rivest's work is mostly in Biochemistry, Genetics and Molecular Biology (44%), Medicine (25%), Immunology and Microbiology (15%).

Life Sciences: 11 works · 59.6% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 44.2% of their workMolecular Biology: 8 works · 42.3% of their workBiotechnology: 0 works · 1.9% of their workImmunology and Microbiology: 3 works · 15.4% of their workImmunology: 3 works · 15.4% of their workHealth Sciences: 4 works · 25.0% of their workMedicine: 4 works · 25.0% of their workOncology: 4 works · 21.2% of their workHematology: 1 works · 3.8% of their workEverything else: 1 works · 7.7% of their workPhysical Sciences: 1 works · 7.7% of their workEngineering: 1 works · 7.7% of their workBiomedical Engineering: 1 works · 7.7% of their workTHEIR WORKBrianna Rivest18works
Life Sciences60%Physical Sciences8%Health Sciences25%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology844.2%
    2. Immunology and Microbiology315.4%
    1. Medicine425.0%
  3. Everything else17.7%
    1. Engineering17.7%
  1. 1Molecular Biology42% of their works
  2. 2Oncology21% of their works
  3. 3Immunology15% of their works
  4. 4Biomedical Engineering8% of their works
  5. 5Hematology4% of their works
  6. 6Biotechnology2% of their works

Research topics

Which keywords describe Brianna Rivest's research?

The keywords of their largest research topics: Cancer Immunotherapy, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, BET Bromodomains, PROTACs, Cancer Therapy and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Immunotherapy142 topics
  2. Immunotherapy122 topics
  3. CAR T Cells81 topic
  4. Chimeric Antigen Receptor81 topic
  5. BET Bromodomains71 topic
  6. PROTACs71 topic
  7. Cancer Therapy62 topics
  8. Dendritic Cells61 topic
  9. Immunity61 topic
  10. RNA Interference61 topic
  11. siRNA Delivery61 topic
  12. HDAC Inhibitors41 topic
  13. Histone Deacetylases41 topic
  14. Nanoparticles41 topic
  15. Photothermal Therapy41 topic
  16. NK Cell Recognition21 topic
  17. Natural Killer Cells21 topic
  18. Proteasome21 topic
  19. Ubiquitin21 topic

Where does Brianna Rivest work?

Brianna Rivest's main affiliation in the publication record is Phio Pharmaceuticals (United States), United States.

How many publications and citations does Brianna Rivest have?

OpenAlex counts 18 works and 14 citations for Brianna Rivest, an h-index of 3, ranking #5,362,341 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Brianna Rivest. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.